New COVID-19 variant in South Africa as massive surge in Europe infections
November 26, 2021Medical Communications
A new variant of coronavirus found in South Africa is feared to be more transmissible than other strains, and poses …
Allorion gains $40 million funding to enhance and discover precision targets
November 26, 2021Medical Communications
Allorion Therapeutics has announced that they have gained $40 million in Series A financing. The funding was led by Chinese …
US government expands COVID-19 booster eligibility ahead of holidays
November 25, 2021Business Services
The Biden administration has expanded COVID-19 booster eligibility, and millions of Americans have received their booster shots at a near …
Groundbreaking success shown in target drug combination for aggressive brain tumours
November 25, 2021Business Services
A combination of two targeted cancer drugs have shown unprecedented activity in patients with highly malignant brain tumours carrying a …
FDA approve first therapy to treat ultra-rare cancer
November 24, 2021Research and Development
Aadi Bioscience announced that the FDA have approved the intravenous drug Fyarro (sirolimus protein-bound particles for injectable suspension) for the …
Ocuphire announces beginning of Phase III trial of treatment for reversal of mydriasis (RM)
November 24, 2021Research and Development
Ocuphire Pharma, a clinical-stage ophthalmic biopharmaceutical company, announced that the first subjects have been enrolled in the MIRA-3 Phase III …
FDA approves Livtencity as first treatment for drug-resistant post-transplant infection
November 24, 2021Manufacturing and Production, Research and Development
The FDA have approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients with a common type …
HUTCHMED and AstraZeneca begin Phase III trial of lung cancer treatment
November 24, 2021Research and Development
HUTCHMED Limited and AstraZeneca have initiated SACHI, a China Phase III study of Savolitinib (ORPATHYS®), an oral, potent, and highly …
Santhera and ReveraGen announce positive results from VISION-DMD study
November 23, 2021Manufacturing and Production
Santhera Pharmaceuticals and ReveraGen BioPharma have announced new topline results after completion of the VISION-DMD study at week 48.
Sterling Pharma Solutions announces £10m investment to increase manufacturing capacity
November 23, 2021Manufacturing and Production
Contract development and manufacturing organisation Sterling Pharma Solutions has announced a £10m multi-year investment strategy for its site in Dudley, …
European Commission approves BYANNLI for management of schizophrenia in adults
November 23, 2021Manufacturing and Production
Johnson & Johnson have announced the approval of the long-acting atypical antipsychotic therapy BYANNLI® by the European Commission (EC), for …
Breakthrough personalised T-cell therapy for children with brain tumours
November 23, 2021Manufacturing and Production
The Centre for Cancer and Immunology Research, Children’s National Research Institute, have developed a new approach that identifies unique proteins …
FDA approves Pfizer and Moderna boosters for all US adults
November 22, 2021Sales and Marketing
The FDA and CDC have cleared the Pfizer and Moderna booster jabs for adults, after reviewing new data supporting the …
FDA accept New Drug Application for Obseva’s linzagolix
November 22, 2021Sales and Marketing
Obseva, a biopharmaceutical company developing and commercialising novel therapies to improve reproductive health, have announced that the NDA for linzagolix …
Novel mechanisms could transform standards of care in multiple cancers, MS, and Lupus
November 22, 2021Sales and Marketing
Leading science and technology company, Merck KGaA, Darmstadt, Germany have identified five mid- to late-stage assets with first-in-class potential for …
Scientists uncover factors influencing waning immunity with Pfizer COVID-19 vaccine
November 22, 2021Sales and Marketing
Scientists have discovered multiple factors influencing declining immunity over time with the Pfizer COVID-19 vaccine, according to News Medical.
Pfizer seek EUA for novel COVID treatment pill
November 19, 2021Medical Communications
Pfizer is seeking FDA Emergency Use Authorisation (EUA) for the novel oral antiviral, Paxlovid. The pill, if authorised, will help …
ImmunityBio expands COVID-19 vaccine programme to incorporate ‘mix-and-match’ technologies
November 19, 2021Medical Communications
Clinical-stage immunotherapy company, ImmunityBio Inc, has announced the expansion of the company’s cancer and infectious disease vaccine programmes to include …
FDA approve Keytruda as adjuvant treatment for kidney cancer
November 19, 2021Medical Communications
The FDA has approved Keytruda® for the treatment of patients with early renal cell carcinoma at high or intermediate-high risk …
NICE recommends at-home treatment for spinal muscular atrophy
November 19, 2021Medical Communications
NICE has recommended risdiplam as treatment for the rare genetic disorder, spinal muscular atrophy, as part of a managed access …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
